Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705897 · ClinicalTrials.gov registry record · NA
PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings
A NA study of Colorectal Cancer, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- NA
- Development phase
- 9,865
- Enrollment target
- 1
- Study location
NCT03705897 is a NA study of Colorectal Cancer that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 9,865 participants, above the 1,484-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (565% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03705897, a NA study of Colorectal Cancer, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 9,865 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of the Parkland-UT Southwestern Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Center is to optimize colon cancer screening through personalized regimens in the integrated safety-net clinical provider network, which serves a large and diverse population of under- and un-insured patients in Dallas. Together, three research projects will assess clinic, system, and organizational factors associated with over-, under- and guideline-based screening among this important population and will compare benefits, harms, and costs of strategies for facilitating optimized screening regimens. The theme of optimizing colorectal cancer screening in a safety-net clinical provider network brings together several components. Its focus on colorectal cancer (CRC) screening which is important, because CRC is the second cancer killer in the US while being the only major cancer for which optimized screening results in primary prevention. Despite this strong potential benefit, CRC screening remains suboptimal overall, and especially among low-income and minority individuals served by safety-nets. Safety-net networks therefore offer tremendous potential for CRC prevention and control, but numerous factors at the clinics-, system-, and organization-level influence their ability to provide optimized care.
Conditions Studied
Interventions
- OTHER Computerized Risk Stratification Tool
- OTHER Algorithmic Risk Stratification Tool
- OTHER Step completion assessment
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9,865 participants |
| Start Date | 2013-08 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03705897
The ClinicalTrials.gov registry entry for NCT03705897 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 9,865 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,484-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (565% higher). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 3 interventions - of which Computerized Risk Stratification Tool is the first listed.
NCT03705897 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03705897 about?
NCT03705897 is a clinical study titled "PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings". The overall goal of the Parkland-UT Southwestern Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) Center is to optimize colon cancer screening through personalized regimens in the integrated safety-net clinical provider network, which serves a large and diverse p...
What is the current status of trial NCT03705897?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 9,865 participants. The study started on 2013-08. Estimated completion is 2026-08.
What conditions does trial NCT03705897 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT03705897?
The interventions under investigation include: Computerized Risk Stratification Tool (OTHER), Algorithmic Risk Stratification Tool (OTHER), Step completion assessment (OTHER).
Who is sponsoring clinical trial NCT03705897?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03705897 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery
RECRUITING · NA
-
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer
RECRUITING · NA
-
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.